User profiles for Yelenis Seijo
 | Yelenis Seijo de ArmasCleveland Clinic Florida Verified email at ccf.org Cited by 51 |
[HTML][HTML] Current understanding of COVID-19 clinical course and investigational treatments
Importance: Currently, there is no unified framework linking disease progression to established
viral levels, clinical tests, inflammatory markers, and investigational treatment options. …
viral levels, clinical tests, inflammatory markers, and investigational treatment options. …
Safety and long-term performance of the Medtronic 3830 lead in His-bundle vs. Left bundle branch area pacing: A single-center 5-year experience
BACKGROUND The short-term safety, feasibility, and performance of the Medtronic
SelectSecure 3830-69 cm pacing lead for conduction system pacing (CSP) has been reported; …
SelectSecure 3830-69 cm pacing lead for conduction system pacing (CSP) has been reported; …
Role of Retrospective Cardiac Computed Tomography Angiography in the Detection of Prosthetic Valve Endocarditis
Case presentation A 47-year-old man was readmitted for evaluation of recurrent fevers, night
sweats, and weight loss over a 3 month period. He had a history of bioprosthetic aortic and …
sweats, and weight loss over a 3 month period. He had a history of bioprosthetic aortic and …
Predictors of Developing Renal Dysfunction Following Diagnosis of Transthyretin Cardiac Amyloidosis
Background: In patients with transthyretin cardiac amyloidosis (ATTR-CA), renal dysfunction
is a poor prognostic indicator. Limited data are available on variables that portend …
is a poor prognostic indicator. Limited data are available on variables that portend …
ATRIAL FIBRILLATION AS A PREDICTOR OF POOR RENAL OUTCOMES IN PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Background Atrial fibrillation (AF) is a common comorbidity among patients with transthyretin
cardiac amyloidosis (ATTR). The extent of the clinical impact of AF in patients with ATTR is …
cardiac amyloidosis (ATTR). The extent of the clinical impact of AF in patients with ATTR is …
[HTML][HTML] A case of cardiac sarcoidosis with successful heart transplantation after COVID-19 infection
Arrhythmogenic right ventricular cardiomyopathy and cardiac sarcoidosis can both present
with ventricular tachycardia. We report a case of a patient whose histological diagnosis was …
with ventricular tachycardia. We report a case of a patient whose histological diagnosis was …
[PDF][PDF] Efficacy of coronary computed tomography angiography versus nuclear perfusion stress in preventing downstream imaging and prolonged inpatient length of …
Background The first-line imaging for low to medium-risk patients presenting to the emergency
department with stable chest pain is often a matter of debate. Chest pain is the second …
department with stable chest pain is often a matter of debate. Chest pain is the second …
B-AB14-04 INTERMEDIATE-TERM PERFORMANCE OF MEDTRONIC 3830 LEAD FOR PHYSIOLOGIC (CONDUCTION SYSTEM) PACING: A SINGLE-CENTER …
Background The short and intermediate-term performance of the Lumenless SelectSecure
3830 lead (Medtronic Inc., Minneapolis, MN) for His bundle pacing has been reported; …
3830 lead (Medtronic Inc., Minneapolis, MN) for His bundle pacing has been reported; …
UTILITY OF THE HEMOTAG™ DEVICE IN ASSESSING LEFT VENTRICULAR DYSFUNCTION
Background The HEMOTAG device, as part of the HATS-OFF (Hemotag AssessmenT for
Short-term Outcomes oF heart Failure) clinical trial, non-invasively measures cardiac time …
Short-term Outcomes oF heart Failure) clinical trial, non-invasively measures cardiac time …
PRESENCE OF TRANSTHYRETIN CARDIAC AMYLOIDOSIS AS AN INDEPENDENT RISK FACTOR OF MORBIDITY REGARDLESS OF EJECTION FRACTION
Background Transthyretin cardiac amyloidosis (ATTR) is recognized as an etiology of heart
failure with preserved ejection fraction (HFpEF) and, in its advanced stages, reduction in …
failure with preserved ejection fraction (HFpEF) and, in its advanced stages, reduction in …
